Mounjaro Price Increase 2025 – What You Need to Know

At Haus of Ästhetik, we believe it is important to provide clear, honest information about major health and wellbeing changes. One significant update relates to Mounjaro (tirzepatide), a treatment used for weight management and type 2 diabetes, which is facing major price changes in the UK.

Mounjaro Treatment Price Changes

From 1 September 2025, Eli Lilly will increase the private market price of Mounjaro in the UK by up to 170%. Reports suggest the highest monthly dose may rise from around £122 to £330. NHS supply and eligibility remain unchanged, but access is still limited.

Why Are Mounjaro Prices Increasing?

• Global price alignment with Europe

• High worldwide demand for Mounjaro

• Manufacturing changes and supply pressures

This shift reflects strong demand for both diabetes and weight management uses.

Staying Safe with Mounjaro

The MHRA has warned about counterfeit and unlicensed products being sold online. Patients are advised to only use UK-qualified prescribers, ensure medication is dispensed by a registered pharmacy, and report issues through the MHRA Yellow Card Scheme.

What This Means for Patients

For private patients, higher costs may be a concern. Discussing alternative GLP-1 medications with a prescriber or checking NHS eligibility criteria may be worthwhile. Looking ahead, expect higher private costs, selective NHS expansion, and improved supply chains as new facilities open.